Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)
Close on Nov 17, 2026Market cap $88.39MP/E –Yield –
Stereotaxis gross margin
Gross margin is gross profit as a percentage of revenue.
Stereotaxis's gross margin for the twelve months ending Jun 30, 2026 was 55.6%. For fiscal 2025 it was 52.7%, against 54.2% the year before. The highest annual figure on record is 80.5% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52.7% | −1.5 |
| FY2024 | Dec 31, 2024 | 54.2% | −1.3 |
| FY2023 | Dec 31, 2023 | 55.5% | −10.1 |
| FY2022 | Dec 31, 2022 | 65.6% | −0.7 |
| FY2021 | Dec 31, 2021 | 66.3% | −4.9 |
| FY2020 | Dec 31, 2020 | 71.2% | −7.5 |
| FY2019 | Dec 31, 2019 | 78.8% | −1.7 |
| FY2018 | Dec 31, 2018 | 80.5% | +15.0 |
| FY2017 | Dec 31, 2017 | 65.5% | −11.1 |
| FY2016 | Dec 31, 2016 | 76.6% | +4.3 |
| FY2015 | Dec 31, 2015 | 72.3% | −4.2 |
| FY2014 | Dec 31, 2014 | 76.5% | +5.4 |
| FY2013 | Dec 31, 2013 | 71.1% | +2.8 |
| FY2012 | Dec 31, 2012 | 68.3% | −2.0 |
| FY2011 | Dec 31, 2011 | 70.2% | −1.0 |
| FY2010 | Dec 31, 2010 | 71.2% | +4.5 |
| FY2009 | Dec 31, 2009 | 66.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 58.5% | +6.4 |
| Q1 FY2026 | Mar 31, 2026 | 60.3% | +5.9 |
| Q4 FY2025 | Dec 31, 2025 | 50.1% | −0.7 |
| Q3 FY2025 | Sep 30, 2025 | 54.9% | +10.4 |
| Q2 FY2025 | Jun 30, 2025 | 52.0% | −21.5 |
| Q1 FY2025 | Mar 31, 2025 | 54.4% | −3.3 |
| Q4 FY2024 | Dec 31, 2024 | 50.7% | −9.3 |
| Q3 FY2024 | Sep 30, 2024 | 44.6% | −7.5 |
| Q2 FY2024 | Jun 30, 2024 | 73.6% | +20.3 |
| Q1 FY2024 | Mar 31, 2024 | 57.6% | −1.5 |
| Q4 FY2023 | Dec 31, 2023 | 60.0% | +1.0 |
| Q3 FY2023 | Sep 30, 2023 | 52.0% | −7.6 |
| Q2 FY2023 | Jun 30, 2023 | 53.3% | −22.6 |
| Q1 FY2023 | Mar 31, 2023 | 59.2% | −10.8 |
| Q4 FY2022 | Dec 31, 2022 | 59.0% | −13.2 |
| Q3 FY2022 | Sep 30, 2022 | 59.6% | +7.7 |
| Q2 FY2022 | Jun 30, 2022 | 75.9% | +3.7 |
| Q1 FY2022 | Mar 31, 2022 | 70.0% | +0.2 |
| Q4 FY2021 | Dec 31, 2021 | 72.2% | −4.3 |
| Q3 FY2021 | Sep 30, 2021 | 52.0% | −1.8 |
| Q2 FY2021 | Jun 30, 2021 | 72.2% | −7.5 |
| Q1 FY2021 | Mar 31, 2021 | 69.8% | −13.7 |
| Q4 FY2020 | Dec 31, 2020 | 76.5% | +1.8 |
| Q3 FY2020 | Sep 30, 2020 | 53.8% | −23.9 |
| Q2 FY2020 | Jun 30, 2020 | 79.7% | −3.4 |
| Q1 FY2020 | Mar 31, 2020 | 83.5% | +3.6 |
| Q4 FY2019 | Dec 31, 2019 | 74.7% | −5.7 |
| Q3 FY2019 | Sep 30, 2019 | 77.7% | −0.7 |
| Q2 FY2019 | Jun 30, 2019 | 83.1% | +1.5 |
| Q1 FY2019 | Mar 31, 2019 | 79.9% | −2.0 |
| Q4 FY2018 | Dec 31, 2018 | 80.3% | +51.5 |
| Q3 FY2018 | Sep 30, 2018 | 78.4% | +2.0 |
| Q2 FY2018 | Jun 30, 2018 | 81.6% | +7.6 |
| Q1 FY2018 | Mar 31, 2018 | 81.9% | −0.1 |
| Q4 FY2017 | Dec 31, 2017 | 28.9% | −43.8 |
| Q3 FY2017 | Sep 30, 2017 | 76.4% | +3.5 |
| Q2 FY2017 | Jun 30, 2017 | 74.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 82.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 72.6% | – |
| Q3 FY2016 | Sep 30, 2016 | 73.0% | – |
See a number that looks wrong?